Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (14902)	2/12/1998 5:57:00 PM
From: Machaon	Read Replies (1) \| Respond to of 32384

Henry, thanks for keeping us current with news and explanations concerning Ligand. LGND's stock rallied from $11 to $20 from March 96 thru May 96; and also rallied from $9 to $14 1/2 from May 97 thru Jun 97. These movements were on much less news and progress than is available right now. I wonder if history will repeat during the first half of this year? From the DJ article: << Targretin product caused a complete regression in 72% of breast cancer tumors in rats. >> Are there any findings yet about Targretin's effect on human tumors, regardless of where they occur? Thanks, Bob